Search
Patexia Research
Case number 1:19-cv-01772

Boehringer Ingelheim Pharmaceuticals Inc. et al v. Macleods Pharmaceuticals Ltd. et al > Documents

Date Field Doc. No.Description (Pages)
Jun 20, 2020 1 Complaint (14)
Apr 14, 2020 19 Main Document (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,673,927 B2; 8,853,156 B2; 9,173,859 B2. (Attachments: # (1) Consent Judgment)(nmf)
Apr 14, 2020 19 Consent Judgment (4)
Apr 14, 2020 19 Patent/Trademark Report to Commissioner (1)
Apr 14, 2020 18 Consent Judgment (4)
Docket Text: CONSENT JUDGMENT Signed by Judge Colm F. Connolly on 4/14/2020. (nmf)
Apr 9, 2020 17 Proposed Consent Judgment (4)
Docket Text: PROPOSED CONSENT JUDGMENT by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan)
Apr 1, 2020 16 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME re: Answer Complaint to April 17, 2020 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Farnan, Kelly)
Apr 1, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [16] STIPULATION TO EXTEND TIME re: Answer Complaint to April 17, 2020 filed by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc., Set/Reset Answer Deadlines: Macleods Pharma USA, Inc. answer due 4/17/2020; Macleods Pharmaceuticals Ltd. answer due 4/17/2020. Signed by Judge Colm F. Connolly on 4/1/2020. (fms)
Mar 19, 2020 N/A SO ORDERED (0)
Mar 19, 2020 15 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for Defendants to Move, Answer, or Otherwise Respond to Complaint to April 3, 2020 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan)
Mar 6, 2020 N/A SO ORDERED (0)
Mar 6, 2020 14 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for Defendants to Move, Answer, or Otherwise Respond to Complaint to March 20, 2020 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan)
Feb 21, 2020 N/A SO ORDERED (0)
Feb 20, 2020 13 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to the Complaint to March 6, 2020 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan)
Feb 7, 2020 N/A SO ORDERED (0)
Feb 7, 2020 12 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME re: Answer to Complaint to February 21, 2020 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Farnan, Kelly)
Jan 8, 2020 N/A SO ORDERED (0)
Jan 8, 2020 11 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to the Complaint to February 7, 2020 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan)
Dec 26, 2019 N/A SO ORDERED (0)
Dec 23, 2019 10 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME re: Answer to Complaint to January 8, 2020 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Farnan, Kelly)
Dec 6, 2019 N/A SO ORDERED (0)
Dec 6, 2019 9 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for Defendants to move, answer, or otherwise respond to the Complaint to December 23, 2019 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Farnan, Kelly)
Nov 22, 2019 N/A SO ORDERED (0)
Nov 22, 2019 8 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME re: Answer Complaint to December 9, 2019 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Farnan, Kelly)
Sep 26, 2019 6 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH: For Macleods Pharma USA, Inc. waiver sent on 9/25/2019, answer due 11/25/2019. (Dellinger, Megan)
Sep 26, 2019 7 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH: For Macleods Pharmaceuticals Ltd. waiver sent on 9/25/2019, answer due 11/25/2019. (Dellinger, Megan)
Sep 25, 2019 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
Sep 20, 2019 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Macleods Pharma USA, Inc. on 9/23/2019; Macleods Pharmaceuticals Ltd. on 9/23/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (kmd)
Sep 20, 2019 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (kmd)
Sep 20, 2019 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,673,927 B2; 8,853,156 B2; 9,173,859 B2. (kmd)
Sep 20, 2019 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/8/2019. Date of Expiration of Patent: 5/4/2027, 3/5/2031, 5/4/2027. Thirty Month Stay Deadline: 2/8/2022. (kmd)
Sep 20, 2019 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd)
Sep 20, 2019 1 Civil Cover Sheet (1)
Sep 20, 2019 1 Main Document (14)
Docket Text: COMPLAINT filed against Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2736428.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # (1) Exhibit 1-3, # (2) Civil Cover Sheet)(kmd)
Sep 20, 2019 1 Exhibit 1-3 (74)
Sep 20, 2019 1 Complaint* (1)
Menu